Notice_of_Intent_to_Issue_Sole_Source_Contract.pdf

Sole Source Notice of Intent for Immunodiagnostic Analyzer & Reagents

The Regional Health Contracting Office-Central, JBSA - Fort Sam Houston, Texas, intends to award a Firm-Fixed-Price sole source bridge contract to Phadia, Incorporated, 4169 Commercial Ave., Portage, Michigan, 49002-9701, under the authority of Federal Acquisition Regulation (FAR) 13.106-1(b)(1)(i), for an Immunodiagnostic Analyzer and Reagents for various allergen and asthma assays for the Department of Pathology, William Beaumont Army Medical Center, El Paso, Texas.

The applicable NAICS code for this requirement is 325413, In-Vitro Diagnostic Substance Manufacturing. The Small Business Size Standard is 1,250 employees.

Phadia, Incorporated, is an other-than small business. Award will be made on or after 24 September 2019.

The solicitation number is W81K0019Q0253, and is generated for the purposes of posting this notice. THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. All responses received, to include capability statements, within five days of the posting of this notice will be considered by the Government. A determination by the Government not to compete the interim purchase order based upon responses to this notice is solely within the discretion of the Government.

Interested sources who submit data are responsible for appropriately marking information if it is proprietary in nature.